Jeng‐Pyng Shaw

2.6k total citations · 1 hit paper
29 papers, 2.2k citations indexed

About

Jeng‐Pyng Shaw is a scholar working on Pharmacology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Jeng‐Pyng Shaw has authored 29 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 10 papers in Infectious Diseases and 9 papers in Molecular Biology. Recurrent topics in Jeng‐Pyng Shaw's work include Antibiotics Pharmacokinetics and Efficacy (9 papers), Antimicrobial Resistance in Staphylococcus (5 papers) and HIV/AIDS drug development and treatment (5 papers). Jeng‐Pyng Shaw is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (9 papers), Antimicrobial Resistance in Staphylococcus (5 papers) and HIV/AIDS drug development and treatment (5 papers). Jeng‐Pyng Shaw collaborates with scholars based in United States and Canada. Jeng‐Pyng Shaw's co-authors include Gerald R. Crabtree, David B. Durand, Paul J. Utz, J J Toole, James A. Fishback, Kenneth M. Kent, Brian C. Froehler, Jeff Bird, Kenneth C. Cundy and William A. Lee and has published in prestigious journals such as Science, Nucleic Acids Research and The Journal of Immunology.

In The Last Decade

Jeng‐Pyng Shaw

29 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of a Putative Regulator of Early T Cell Activation Genes

1988 799 citations Jeng‐Pyng Shaw, Paul J. Utz et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeng‐Pyng Shaw United States	18	1.1k	538	516	292	259	29	2.2k
Yuji Iizawa Japan	23	700 0.6×	621 1.2×	1.2k 2.3×	486 1.7×	211 0.8×	46	2.8k
Ronald P. McCaffrey United States	26	856 0.7×	522 1.0×	444 0.9×	263 0.9×	228 0.9×	59	2.6k
Jeffrey L. Nordstrom United States	29	1.9k 1.7×	292 0.5×	489 0.9×	210 0.7×	93 0.4×	63	3.6k
Marian Gorecki Israel	31	971 0.8×	305 0.6×	240 0.5×	302 1.0×	89 0.3×	63	2.2k
Kazutaka Oda Japan	21	982 0.9×	414 0.8×	239 0.5×	257 0.9×	369 1.4×	80	2.2k
Tae Woo Kim South Korea	31	1.4k 1.3×	267 0.5×	937 1.8×	386 1.3×	69 0.3×	88	2.8k
Debashis Mitra India	31	1.1k 0.9×	493 0.9×	956 1.9×	433 1.5×	124 0.5×	99	2.8k
Shridhar Bhat United States	21	1.5k 1.3×	333 0.6×	203 0.4×	345 1.2×	133 0.5×	37	2.6k
Scott M. Laster United States	20	1.1k 0.9×	178 0.3×	620 1.2×	210 0.7×	120 0.5×	45	2.0k
Marc Aumercier France	20	668 0.6×	313 0.6×	428 0.8×	306 1.0×	122 0.5×	43	1.5k

Countries citing papers authored by Jeng‐Pyng Shaw

Since Specialization

Citations

This map shows the geographic impact of Jeng‐Pyng Shaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeng‐Pyng Shaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeng‐Pyng Shaw more than expected).

Fields of papers citing papers by Jeng‐Pyng Shaw

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeng‐Pyng Shaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeng‐Pyng Shaw. The network helps show where Jeng‐Pyng Shaw may publish in the future.

Co-authorship network of co-authors of Jeng‐Pyng Shaw

This figure shows the co-authorship network connecting the top 25 collaborators of Jeng‐Pyng Shaw. A scholar is included among the top collaborators of Jeng‐Pyng Shaw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeng‐Pyng Shaw. Jeng‐Pyng Shaw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Armstrong, Scott R., David T. Beattie, Daniel D. Long, et al.. (2013). Discovery of TD-8954, a clinical stage 5-HT4 receptor agonist with gastrointestinal prokinetic properties. Bioorganic & Medicinal Chemistry Letters. 23(14). 4210–4215. 12 indexed citations

Long, Daniel D., Scott R. Armstrong, David T. Beattie, et al.. (2012). Discovery, oral pharmacokinetics and in vivo efficacy of velusetrag, a highly selective 5-HT4 receptor agonist that has achieved proof-of-concept in patients with chronic idiopathic constipation. Bioorganic & Medicinal Chemistry Letters. 22(19). 6048–6052. 16 indexed citations

Long, Daniel D., Scott R. Armstrong, David T. Beattie, et al.. (2012). Discovery, oral pharmacokinetics and in vivo efficacy of a highly selective 5-HT4 receptor agonist: Clinical compound TD-2749. Bioorganic & Medicinal Chemistry Letters. 22(14). 4849–4853. 8 indexed citations

Long, Daniel D., Bryan A. Frieman, Sharath S. Hegde, et al.. (2012). A multivalent approach towards linked dual-pharmacology prostaglandin F receptor agonist/carbonic anhydrase-II inhibitors for the treatment of glaucoma. Bioorganic & Medicinal Chemistry Letters. 23(4). 939–943. 15 indexed citations

Shaw, Jeng‐Pyng, et al.. (2010). Pillars Article: Identification of a Putative Regulator of Early T Cell Activation Genes. Science. 1988. 241: 202–205. The Journal of Immunology. 185(9). 4972–4975. 1 indexed citations

Goldberg, Michael R., Shekman Wong, Jeng‐Pyng Shaw, Michael M. Kitt, & Steven L. Barriere. (2010). Single‐Dose Pharmacokinetics and Tolerability of Telavancin in Elderly Men and Women. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 30(8). 806–811. 18 indexed citations

Shaw, Jeng‐Pyng, et al.. (2010). Identification of a putative regulator of early T cell activation genes. Science. 1988. 241: 202-205.. PubMed. 185(9). 4972–5. 65 indexed citations

Goldberg, Michael R., Shekman Wong, Jeng‐Pyng Shaw, Michael M. Kitt, & Steven L. Barriere. (2009). Lack of Effect of Moderate Hepatic Impairment on the Pharmacokinetics of Telavancin. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 30(1). 35–42. 17 indexed citations

Cass, Robert, et al.. (2004). Increasing the efficiency of pharmacokinetic sample procurement, preparation and analysis by liquid chromatography/tandem mass spectrometry. Rapid Communications in Mass Spectrometry. 18(10). 1066–1072. 3 indexed citations

10.

Leadbetter, Michael R., Dane E. Karr, Kevin M. Krause, et al.. (2004). Hydrophobic Vancomycin Derivatives with Improved ADME Properties: Discovery of Telavancin (TD-6424). The Journal of Antibiotics. 57(5). 326–336. 126 indexed citations

11.

Oliyai, Reza, et al.. (1999). Aryl Ester Prodrugs of Cyclic HPMPC. I: Physicochemical Characterization and In Vitro Biological Stability. Pharmaceutical Research. 16(11). 1687–1693. 18 indexed citations

12.

Cundy, Kenneth C., et al.. (1998). Pharmacokinetics and Bioavailability of the Anti-Human Immunodeficiency Virus Nucleotide Analog 9-[( R )2-(Phosphonomethoxy)Propyl]Adenine (PMPA) in Dogs. Antimicrobial Agents and Chemotherapy. 42(3). 687–690. 60 indexed citations

13.

Cundy, Kenneth C., et al.. (1997). Oral Formulations of Adefovir Dipivoxil: In Vitro Dissolution and in Vivo Bioavailability in Dogs. Journal of Pharmaceutical Sciences. 86(12). 1334–1338. 26 indexed citations

14.

Shaw, Jeng‐Pyng, Reza Oliyai, William A. Lee, et al.. (1997). Metabolism and Pharmacokinetics of Novel Oral Prodrugs of 9-[(R)-2-(phosphonomethoxy)propyl]adenine (PMPA) in Dogs. Pharmaceutical Research. 14(12). 1824–1829. 102 indexed citations

15.

Cundy, Kenneth C., et al.. (1996). Distribution and metabolism of intravitreal cidofovir and cyclic HPMPC in rabbits. Current Eye Research. 15(5). 569–576. 20 indexed citations

16.

Lee, William A., et al.. (1995). A Novel Oligodeoxynucleotide Inhibitor of Thrombin. II. Pharmacokinetics in the Cynomolgus Monkey. Pharmaceutical Research. 12(12). 1943–1947. 14 indexed citations

17.

Shaw, Jeng‐Pyng, James A. Fishback, Kenneth C. Cundy, & William A. Lee. (1995). A Novel Oligodeoxynucleotide Inhibitor of Thrombin. I. In VitroMetabolic Stability in Plasma and Serum. Pharmaceutical Research. 12(12). 1937–1942. 16 indexed citations

18.

Cundy, Kenneth C., James A. Fishback, Jeng‐Pyng Shaw, et al.. (1994). Oral Bioavailability of the Antiretroviral Agent 9-(2-phosphonylmethoxyethyl)adenine (PMEA) from Three Formulations of the Prodrug Bis(pivaloyloxymethyl)-PMEA in Fasted Male Cynomolgus Monkeys. Pharmaceutical Research. 11(6). 839–843. 59 indexed citations

19.

Shaw, Jeng‐Pyng, Kenneth M. Kent, Jeff Bird, James A. Fishback, & Brian C. Froehler. (1991). Modified deoxyoligonucleotides stable to exonuclease degradation in serum. Nucleic Acids Research. 19(4). 747–750. 327 indexed citations

20.

Shaw, Jeng‐Pyng, Jonathan Marks, & Che-Kun James Shen. (1991). The adult α-globin locus of old world monkeys: An abrupt breakdown of sequence similarity to human is defined by an Alu family repeat insertion site. Journal of Molecular Evolution. 33(6). 506–513. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact